Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2021-05-17
2022-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a 16-day Hot and Cold Acclimation on Adaptive Responses and Health-related Indicators
NCT06346639
Effects of Winter Swimming on Blood Indicators and Oxidative Stress in Males
NCT06223087
Effects of Physical Training in Altered Environmental Conditions on Exercise Performance
NCT06159374
Evaluation of the Response to Hypoxia at Rest and During Exercise in a Healthy Subject After a Cryostimulation Exposure
NCT06174480
The Association Between Sedentary Behaviour and Cardiometabolic Health in Trained Athletes
NCT04711928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cold exposure applied to Western European individuals
Participants rested under thermoneutral conditions for 30 min, which was then followed by exposure to \~ 9°C air temperature for a maximum of 1 hour. Same duration as matched Siberian individuals.
Cold exposure
Cold air exposure (\~ 9°C, maximum 1 hour duration)
Cold exposure applied to Siberian individuals
Participants rested under thermoneutral conditions for 30 min, which was then followed by exposure to \~ 9°C air temperature for a maximum of 1 hour. Same duration as matched European individuals.
Cold exposure
Cold air exposure (\~ 9°C, maximum 1 hour duration)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cold exposure
Cold air exposure (\~ 9°C, maximum 1 hour duration)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Western European origin or of Siberian origin
* BMI between 18.5 and 35 kg/m2
* Generally healthy (determined by dependent physician)
Exclusion Criteria
* Active, uncontrolled cardiovascular disease or cancer
* Raynaud's disease
* Participation in another biomedical study within 1 month before the first study
* Cold-acclimated (Western European group), such as takes daily extended cold baths, works in a refrigerated environment, or regular cold-water swimming within 1 month of starting the study
* Medication use known to hamper subject's safety during study procedures
* Abuse of alcohol or drugs
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
W. van Marken Lichtenbelt, PhD
Role: PRINCIPAL_INVESTIGATOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WEU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.